default author photo

William E. Fogler

GlycoMimetics Inc

SCHOLARLY PAPERS

1

DOWNLOADS

91

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

E-Selectin Inhibition Overcomes Endothelial Niche-Mediated Resistance to Bcl-2–Targeted Therapy in AML

Number of pages: 27 Posted: 20 Oct 2022
University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, University of Texas at Houston - Section of Molecular Hematology and Therapy, GlycoMimetics Inc, GlycoMimetics Inc, University of Texas at Houston - Section of Molecular Hematology and Therapy and University of Texas at Houston - Section of Molecular Hematology and Therapy, Department of Leukemia
Downloads 91 (736,406)

Abstract:

Loading...

acute myeloid leukemia, leukemia stem cells, E-selectin, Bcl-2, antagonist